US Tariffs on UK Goods Hold Steady at 10% as Legal Challenges and Trade Negotiations Continue in 2025

Listeners, welcome to United Kingdom Tariff News and Tracker. The big story this week centers on the dynamic state of US tariffs affecting the United Kingdom and fresh developments from Washington. Here’s what’s driving the headlines as of November 2025. British-made goods shipped to the US, especially vehicles, are drawing close scrutiny from importers, as tariffs currently stand at 10%. This figure is notably lower than the 15% levied on most EU and Japanese vehicles. According to West Coast Shipping’s latest shipping guide as of April 2025, British-origin cars benefit from this 10% tariff rate for containers entering the US, with the rate generally applying to the first 100,000 units imported from the UK per year—a quota system verified by trade analysts at TPE Japan. Import costs for a vehicle from the UK to New York remain steady at around $2,750 in ocean freight, with a typical transit time of 26 days. Listeners should note that there is still uncertainty in the future trajectory of these tariff rates as legal challenges and executive actions continue to reshape trade dynamics. The US Supreme Court is currently hearing arguments over the legal authority the administration—under President Donald Trump in his current second term—has for imposing tariffs under the International Emergency Economic Powers Act. The outcome could either reinforce or overturn the government's ability to set reciprocal tariffs, impacting all partners, including the UK. Chamber International reports that while no tariff rates have changed for UK goods just yet, these court decisions could shift the ground for UK exporters and US importers. The Trump administration’s reciprocal tariff strategy, first outlined earlier this year to counter non-reciprocal trade deals, led to a baseline 10% tariff against nearly all US trading partners, along with country-specific rates. The UK, however, managed to negotiate this 10% level in recent talks with US trade officials, putting it among the lower-rate countries for several key exports, particularly compared to other European nations. In related news, while much attention has focused on manufacturing and automotive sectors, the pharmaceutical industry is also under the microscope. Recent negotiations between the White House and leading pharma companies from the UK and elsewhere have delayed new industry-specific tariffs for at least three years, with both Pfizer and AstraZeneca reaching agreements to avoid immediate additional levies in exchange for increased US manufacturing and price parity measures. DCAT Value Chain Insights highlights that these deals, plus the ongoing Section 232 investigation by the US Commerce Department, will be critical for UK drug exporters to monitor into 2026. For now, listeners moving goods from the UK to the US can rely on a 10% tariff for most vehicles within quota, and a generally stable but closely watched environment for other key exports. With high-level legal battles pending and bilateral This content was created in partnership and with the help of Artificial Intelligence AI.